$3.32T
Total marketcap
$103.68B
Total volume
BTC 57.46%     ETH 11.97%
Dominance

Oncoinvent ASA BRRGF Stock

$0.97   0.000000%
Add to favorites
Market Cap
$237.33M
LOW - HIGH [24H]
$0.02 - $0.02
VOLUME [24H]
$37.31K
P/E Ratio
0
Earnings per share
-$2.04
Price   Prediction

Oncoinvent ASA Price Chart

Sorry, that's all we've gotfor now...

Oncoinvent ASA BRRGF Financial and Trading Overview

Oncoinvent ASA stock price 0.97 USD
Previous Close {summary_details__previousClose}
Open {summary_details__open}
Bid {summary_details__bid} x {summary_details__bidSize}
Ask {summary_details__ask} x {summary_details__askSize}
Day's Range 1.77 - 1.77 USD
52 Week Range 1.77 - 1.77 USD
Volume {summary_details__volume}
Avg. Volume {summary_details__averageVolume}
Market Cap {summary_details__marketCap}
Beta (5Y Monthly) {summary_details__beta}
PE Ratio (TTM) {summary_details__trailingPE}
EPS (TTM) -2.04 USD
Forward Dividend & Yield {summary_details__dividendRate} ({summary_details__dividendYield})
Ex-Dividend Date {summary_details__exDividendDate}
1y Target Est {financial_data__targetMeanPrice}

BRRGF Valuation Measures

Enterprise Value {default_key_statistics__enterpriseValue}
Trailing P/E {summary_details__trailingPE}
Forward P/E {summary_details__forwardPE}
PEG Ratio (5 yr expected) {default_key_statistics__pegRatio}
Price/Sales (ttm) {summary_details__priceToSalesTrailing12Months}
Price/Book (mrq) {default_key_statistics__priceToBook}
Enterprise Value/Revenue {default_key_statistics__enterpriseToRevenue}
Enterprise Value/EBITDA {default_key_statistics__enterpriseToEbitda}

Trading Information

Oncoinvent ASA Stock Price History

Beta (5Y Monthly) {default_key_statistics__beta}
52-Week Change {default_key_statistics__52WeekChange}
S&P500 52-Week Change {default_key_statistics__SandP52WeekChange}
52 Week High {summary_details__fiftyTwoWeekHigh}
52 Week Low {summary_details__fiftyTwoWeekLow}
50-Day Moving Average {summary_details__fiftyDayAverage}
200-Day Moving Average {summary_details__twoHundredDayAverage}

BRRGF Share Statistics

Avg. Volume (3 month) {summary_details__averageVolume}
Avg. Daily Volume (10-Days) {summary_details__averageDailyVolume10Day}
Shares Outstanding {default_key_statistics__sharesOutstanding}
Float {default_key_statistics__floatShares}
Short Ratio {default_key_statistics__shortRatio}
% Held by Insiders {default_key_statistics__heldPercentInsiders}
% Held by Institutions {default_key_statistics__heldPercentInstitutions}
Shares Short {default_key_statistics__sharesShort}
Short % of Float {default_key_statistics__shortPercentOfFloat}
Short % of Shares Outstanding {default_key_statistics__sharesPercentSharesOut}

Dividends & Splits

Trailing Annual Dividend Rate {summary_details__trailingAnnualDividendRate}
Trailing Annual Dividend Yield {summary_details__trailingAnnualDividendYield}
5 Year Average Dividend Yield {summary_details__fiveYearAvgDividendYield}
Payout Ratio {summary_details__payoutRatio}
Last Split Factor {default_key_statistics__lastSplitFactor}

Financial Highlights

Fiscal Year

Fiscal Year Ends {default_key_statistics__lastFiscalYearEnd}
Most Recent Quarter (mrq) {default_key_statistics__mostRecentQuarter}
Next Fiscal Year End {default_key_statistics__nextFiscalYearEnd}

Profitability

Profit Margin {financial_data__profitMargins}
Operating Margin (ttm) {financial_data__operatingMargins}
Gross Margin {financial_data__grossMargins}
EBITDA Margin {financial_data__ebitdaMargins}

Management Effectiveness

Return on Assets (ttm) {financial_data__returnOnAssets}
Return on Equity (ttm) {financial_data__returnOnEquity}

Income Statement

Revenue (ttm) {financial_data__totalRevenue}
Revenue Per Share (ttm) {financial_data__revenuePerShare}
Quarterly Revenue Growth (yoy) {financial_data__revenueGrowth}
Gross Profit (ttm) {financial_data__grossProfits}
EBITDA {financial_data__ebitda}
Net Income Avi to Common (ttm) {default_key_statistics__netIncomeToCommon}
Diluted EPS (ttm) {default_key_statistics__trailingEps}
Quarterly Earnings Growth (yoy) {default_key_statistics__earningsQuarterlyGrowth}

Balance Sheet

Total Cash (mrq) {financial_data__totalCash}
Total Cash Per Share (mrq) {financial_data__totalCashPerShare}
Total Debt (mrq) {financial_data__totalDebt}
Total Debt/Equity (mrq) {financial_data__debtToEquity}
Current Ratio (mrq) {financial_data__currentRatio}
Book Value Per Share (mrq) {default_key_statistics__bookValue}

Cash Flow Statement

Operating Cash Flow (ttm) {financial_data__operatingCashflow}
Levered Free Cash Flow (ttm) {financial_data__freeCashflow}

Profile of Oncoinvent ASA

Country United States
State {summary_profile__state}
City {summary_profile__city}
Address {summary_profile__address1}
ZIP {summary_profile__zip}
Phone {summary_profile__phone}
Website {summary_profile__website}
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees {summary_profile__fullTimeEmployees}

{summary_profile__longBusinessSummary}

Q&A For Oncoinvent ASA Stock

What is a current BRRGF stock price?

Oncoinvent ASA BRRGF stock price today per share is 0.97 USD.

How to purchase Oncoinvent ASA stock?

You can buy BRRGF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Oncoinvent ASA?

The stock symbol or ticker of Oncoinvent ASA is BRRGF.

Which industry does the Oncoinvent ASA company belong to?

The Oncoinvent ASA industry is Biotechnology.

How many shares does Oncoinvent ASA have in circulation?

The max supply of Oncoinvent ASA shares is 244.44M.

What is Oncoinvent ASA Price to Earnings Ratio (PE Ratio)?

Oncoinvent ASA PE Ratio is now.

What was Oncoinvent ASA earnings per share over the trailing 12 months (TTM)?

Oncoinvent ASA EPS is -2.04 USD over the trailing 12 months.

Which sector does the Oncoinvent ASA company belong to?

The Oncoinvent ASA sector is Healthcare.

✨New! Portfolio🚀